IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Sheel Biotech Ltd.
Issue Open Date 30-Sep-25  
Issue Closing Date 03-Oct-25  
Application Money 100  
Allotment Money  
Price Band 59 - 63  
Minimium Application No. 4000  
Issue Size (Shares) 3876000  
Market Lot 1.00  
Objective
1. To meet our the Capital Expenditure requirements of the company2. To meet out the expenses for Working capital requirement for the company3. To meet out the expenses for General Corporate Purpose
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors     20352000   NA  
Qualified Institutional Buyers     20244000   NA  
Retail Individual Investors     17260000   NA  
Business Description
Our Company is engaged in the business of growing, developing, processing, and supplying a wide range ofplants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. Wemanufacture and maintain greenhouses, offer
more...
Promoter's Holding
Total Share Capital   14502250  
Offered to Public   5400000  
Promoter's Holding (Pre-Issue)   96.99  
Promoter's Holding (Post-Issue)   71.26  
Address
8 Balaji Estates
2nd Floor
Block- C
Guru Ravidas Marg
Kalkaji
South Delhi
New Delhi ,
Delhi ,
110019
Phone: 8851189801
Email: compliance@sheelbiotech.com
Website: www.sheelbiotech.com
Registrar
Skyline Financial Services Pvt Ltd
D-153/A
1st Floor
Okhla Industrial Area
Phase - I
New Delhi
Listed at
NSE
Lead Manager
Narnolia Financial Services Ltd.
Promoters
Divye Chandak
Mini Chadha
Sanjay Chandak
Sanjay Chandak (HUF)
Satya Narayan Chandak
Satya Narayan Chandak (HUF)
Sumeet Chandak (HUF)
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.